45 results
6-K
EX-99.1
GNFT
Genfit
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
nature of the medicine concerned. There can be no guarantees a medicine will receive the necessary regulatory approvals or that the medicine will prove
6-K
EX-99.1
GNFT
Genfit
13 Nov 23
Current report (foreign)
4:30pm
will be sufficient to demonstrate the safe and effective nature of the medicine concerned. There can be no guarantees a medicine will receive
6-K
EX-99.1
z5a3tzmh2 1t6on
26 Sep 23
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
4:10pm
6-K
EX-99.1
jrq958bfumf7f
20 Sep 23
Current report (foreign)
4:44pm
6-K
EX-99.1
3m5tje 6fuif7zryhu
30 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.2
9yllqk5a1fdkuybdl
19 Apr 23
Current report (foreign)
4:10pm
F-3
yr1usbg8zs4jy3qyq
18 Apr 23
Shelf registration (foreign)
2:33pm
6-K
EX-99.1
67aagqj
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
EX-99.2
eegwxgv8ymxx e1
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm